tiprankstipranks
Atossa Therapeutics (ATOS)
NASDAQ:ATOS

Atossa Therapeutics (ATOS) Financial Statements

1,922 Followers

Atossa Therapeutics Financial Overview

Atossa Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.235; its P/E ratio is -7.76; Atossa Therapeutics is scheduled to report earnings on March 28, 2024, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -6.23M$ -9.83M$ -6.28M$ -8.37M$ -8.21M
EBITDA$ -6.23M$ -9.83M$ -6.28M$ -8.37M$ -8.20M
Net Income Common Stockholders$ -6.23M$ -9.83M$ 7.92M$ -7.49M$ -8.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 94.03M$ 99.50M$ 103.98M$ 111.00M$ 117.37M
Total Assets$ 101.69M$ 108.36M$ 115.46M$ 123.53M$ 126.72M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -94.03M$ -99.50M$ -103.98M$ -111.00M$ -117.37M
Total Liabilities$ 3.44M$ 3.48M$ 2.94M$ 5.57M$ 2.87M
Stockholders Equity$ 98.25M$ 104.88M$ 113.26M$ 117.96M$ 123.86M
Cash Flow-
Free Cash Flow$ -3.88M$ -4.48M$ 111.11M-$ -5.42M
Operating Cash Flow$ -3.88M$ -4.46M$ 111.11M-$ -5.41M
Investing Cash Flow$ -1.00K$ -13.00K--$ -2.71M
Financing Cash Flow$ -1.48M---$ 0.00
Currency in USD

Atossa Therapeutics Earnings and Revenue History

Atossa Therapeutics Debt to Assets

Atossa Therapeutics Cash Flow

Atossa Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis